Context Accurate staging of high-risk localised, advanced, and metastatic prostate cancer is
becoming increasingly more important in guiding local and systemic treatment. Gallium-68 …

Prostate-specific membrane antigen (PSMA) has been the subject of extensive investigation
in the past two decades as a promising molecular target for prostate cancer (PCa). Its …

The role of prostate-specific membrane antigen (PSMA)–targeted PET in comparison to
multiparametric MRI (mpMRI) in the evaluation of intraprostatic cancer foci is not well …

Prostate-specific membrane antigen PET/CT for primary staging of prostate cancer is
becoming increasingly popular due to simultaneous assessment of whole-body disease …

Objectives To review the literature to determine the sensitivity and specificity of gallium‐68
prostate‐specific membrane antigen (68Ga‐PSMA) positron‐emission tomography (PET) for …

18F-DCFPyL (2-(3-{1-carboxy-5-[(6-18F-fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-
pentanedioic acid), a prostate-specific membrane antigen–targeting radiotracer, has shown …

Prostate cancer is the second most common cause of malignancy among men, with bone
metastasis being a significant source of morbidity and mortality in advanced cases …

Purpose To prospectively compare diagnostic accuracies for detection of bone metastases
by 68 Ga-PSMA PET/CT, 18 F-NaF PET/CT and diffusion-weighted MRI (DW 600-MRI) in …

Purpose Bone scintigraphy with 99m Tc-labeled diphosphonates can identify prostate
cancer bone metastases with high sensitivity, but relatively low specificity, because benign …

Please see the Editorial Comment by Sungmin Woo discussing this article. BACKGROUND.
Bone scintigraphy (BS) using 99mTc-labeled methylene diphospho-nate (99mTc-MDP) …